Gland Pharma Limited

Hyderabad, India

Sterile Injectables (vials, prefilled syringes, lyophilized) Oncology Injectables Ophthalmic Injectables Complex Injectables (505(b)(2), NCE-1, First-to-File) Sterile API (including GLP-1 / Liraglutide) Biosimilars Dual-Chamber Bags / Combination Devices Sterile Fill-Finish (via Cenexi acquisition, France/Belgium)

Program data pending ClinicalTrials.gov matching

60.0

Signal Score

○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (8) ○ EMA GMP ○ MHRA GMP

Quick Facts: Gland Pharma Limited

Signal Score: 60.0/100
Quality Compliance: Assessment pending
Headquarters: Hyderabad, India
Modalities: Sterile Injectables (vials, prefilled syringes, lyophilized), Oncology Injectables, Ophthalmic Injectables, Complex Injectables (505(b)(2), NCE-1, First-to-File), Sterile API (including GLP-1 / Liraglutide), Biosimilars, Dual-Chamber Bags / Combination Devices, Sterile Fill-Finish (via Cenexi acquisition, France/Belgium)
Active Programs: No ClinicalTrials.gov matches confirmed
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CDMO intelligence platform

About Gland Pharma Limited

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

No FDA inspection records found for this manufacturer

Quality score requires FDA inspection data

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs — no verified data

Sponsors— no verified data

ModalitiesSterile Injectables (vials, prefilled syringes, lyophilized), Oncology Injectables, Ophthalmic Injectables, Complex Injectables (505(b)(2), NCE-1, First-to-File), Sterile API (including GLP-1 / Liraglutide), Biosimilars, Dual-Chamber Bags / Combination Devices, Sterile Fill-Finish (via Cenexi acquisition, France/Belgium)

No clinical trial matches found for this manufacturer

Operational score requires ClinicalTrials.gov data

Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.

Financial Stability

Profile-based financial assessment

SEC FilingsPrivate company

Private company

Financial assessment: 60.0/100

Capacity

Profile-based capacity assessment

Recent Press8 articles

Broad modality coverage (8 modalities)